18 July 2023 - trading update
The AIM-listed international healthcare group has issued a trading update covering the six months to 30 June and this has revealed only a modest 1% rise in revenue for the period as this rose to £82.4m. The first half saw a mixed-performance with some regulatory issues delaying manufacturing in certain smaller products although elsewhere the business performed in reasonable fashion. The shares have clearly fallen back a long way since peaking at 72p in both March and May and are now back at a solid entry point - BUY.
This content is restricted to members only. We offer three packages from 1 month to a whole year of daily tips, market news and commentary, plus our monthly newsletters.
Registration is quick and simple HERE.
Already a member, log in HERE.
